This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2024 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Dawn Holcombe, MBA FACMPE ACHE
President at DGH Consulting
Speaker

Profile

Now a private consultant to providers, payers, employers and pharma, Dawn Holcombe's experience includes payer/provider/employer trends. strategy and relations, and healthcare quality/value programs, especially in the field of oncology. She is the Editor -in-Chief of the national Oncology Practice Management journal, a past President of the national Administrators in Oncology Hematology Assembly (AOHA) of the Medical Group Management Association (MGMA) and is a Fellow in the American College of Medical Practice Executives (ACMPE), earning her MBA at the University of Michigan. She also serves as the President of the National Oncology State Network (NOSN), the Executive Director of the Connecticut Oncology Association, the Director of the Oncology Institute for the NAMCP Medical Directors, and an oncology advisor with the Association of Corporate Health Risk Managers.

Agenda Sessions

  • The Basics of Alternative Funding Programs

    1:05pm
  • Panel Discussion on Industry Impact and Response

    2:00pm
  • Think Tank Discussion

    3:30pm